Management of an acute coronary syndrome in a patient with severe haemophilia A.
Ferrario
C
C
Renders
F
F
Cairoli
A
A
Vuffray
A
A
Spertini
O
O
Angelillo-Scherrer
A
A
D054058:Acute Coronary Syndrome / Q000150:complications / Q000188:drug therapy*; D000933:Antifibrinolytic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications*; D006490:Hemostatics / Q000009:adverse effects* / Q000494:pharmacology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008017:Life Expectancy / Q000639:trends; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D006490:Hemostatics; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin